“…In general, molecular methods can be divided into those allowing specific detection of M. bovis (using either conventional or real‐time PCRs; Cai, Bell‐Rogers, Parker, & Prescott, ; Ghadersohi, ; Hotzel, Sachse, & Pfützner, ; Rossetti, Frey, & Pilo, ; Sachse et al., ; Subramaniam et al., ) and those allowing simultaneous detection of M. bovis with other mycoplasma species or Mollicutes . The latter includes multiplex PCRs (Boonyayatra et al., ; Cornelissen et al., ; Gioia, Werner, Nydam, & Moroni, ; Justice‐Allen, Trujillo, Goodell, & Wilson, ; Parker, House, Hazelton, Bosward, & Sheehy, ; Righter, Rurangirwa, Call, & McElwain, ), PCR with denaturing gradient gel electrophoresis (DGGE); (McAuliffe, Ellis, Lawes, Ayling, & Nicholas, ) and a DNA microarray based on oligonucleotide probes derived from the 23S rRNA gene and species‐specific probes from the tuf gene target (Bottinelli et al., ; Schnee et al., ). It is important to note that although multiplex detection may help in the diagnosis of mixed mollicute infections, it may introduce additional complexity into the determination of disease aetiology; multiple mycoplasma species may be found, for example, in the upper respiratory or genital tracts that are apparent commensals with questionable significance in disease (Brown et al., ).…”